Inovio Pharmaceuticals Inc. Stock Rallies 5.5%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. rose 5.5% to $1.15 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,644.91 and Dow Jones Industrial Average falling 0.5% to 53,459.78.

This was the stock's sixth consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 61.4% short of its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $262.37, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.30% to $26.87.

Trading volume totaled 6.4 million, compared to the 50-day average of 3.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 17, 2026 16:34 ET (20:34 GMT)